ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Cancer Control Budget Still $4 Million Short

January 28, 1977

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

NCI CTEP Approved Trials For the Month of November

November 29, 2013

Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.

February 20, 2004

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012